Microbial lipopolysaccharides are the main agonists of TLR4, but saturated fatty acids and fibrinogen have been suggested as stimuli for TLR4 dimerization and signaling cascade activation in the context of obesity [21,52]. The gene discussed is TLR4; the disease is obesity disorder.